ZNF821 inhibitors refer to a class of chemical compounds designed to inhibit the activity of the ZNF821 protein, which is a zinc finger protein involved in the regulation of gene expression. ZNF821, like other members of the zinc finger protein family, functions primarily as a transcription factor, binding to specific DNA sequences to regulate the expression of various genes. Zinc finger domains are well-known for their role in DNA binding, and the inhibition of proteins like ZNF821 can significantly impact cellular processes such as proliferation, differentiation, and response to external signals. ZNF821 is particularly notable for its role in controlling transcriptional networks that influence cellular signaling and gene regulation, often acting at the interface of critical molecular pathways that govern cellular function.
The inhibition of ZNF821 can disrupt its ability to modulate these transcriptional pathways, leading to broad changes in cellular gene expression. This can have downstream effects on protein synthesis, metabolic pathways, and cell cycle regulation, depending on the specific genes affected. Researchers studying ZNF821 inhibitors are particularly interested in how these molecules can modulate the protein's zinc finger domain, altering its DNA-binding affinity or preventing its interaction with co-factors required for transcriptional activity. Structurally, ZNF821 inhibitors are often designed to interfere with key regions of the protein, such as its zinc finger motifs, and can act through competitive or allosteric mechanisms. This inhibition presents valuable insights into the biochemical mechanisms that govern transcriptional control and protein-DNA interactions. Understanding the molecular characteristics of these inhibitors aids in the study of gene regulatory networks and cellular signaling processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor can alter gene expression patterns, including those genes associated with ZNF821, potentially affecting its expression or function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
An isoflavone that acts as a tyrosine kinase inhibitor, which can alter cell signaling pathways and potentially impact ZNF821 if it is regulated by such kinases. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
A cyclin-dependent kinase inhibitor that may disrupt cell cycle regulation, potentially influencing ZNF821 if its function is linked to cell cycle progression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can increase protein levels by preventing degradation, which may affect ZNF821 stability and function. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A CDK4/6 inhibitor that may alter cell cycle progression and thus potentially affect ZNF821 if it is involved in cell cycle control. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Another CDK inhibitor that can affect cell cycle progression and transcriptional regulation, potentially impacting ZNF821 function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that can change chromatin structure and gene expression, potentially altering the expression of ZNF821 or proteins that regulate ZNF821. | ||||||
CI 994 | 112522-64-2 | sc-205245 sc-205245A | 10 mg 50 mg | $99.00 $536.00 | 1 | |
A histone deacetylase inhibitor that can affect gene expression and may influence ZNF821 expression or its associated regulatory proteins. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor that blocks the MAPK/ERK pathway, potentially altering the phosphorylation status and activity of ZNF821 if it is downstream of this signaling cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can disrupt the PI3K/AKT signaling, potentially altering ZNF821 regulation if ZNF821 is PI3K/AKT pathway dependent. | ||||||